Suven Life Sciences Limited Stock NSE India S.E.
Equities
SUVEN
INE495B01038
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
112.6 INR | +0.99% | +8.17% | +39.38% |
Sales 2022 | 120M 1.43M 1.95M | Sales 2023 | 136M 1.63M 2.22M | Capitalization | 10.57B 127M 173M |
---|---|---|---|---|---|
Net income 2022 | -1.22B -14.63M -19.95M | Net income 2023 | -1.18B -14.19M -19.35M | EV / Sales 2022 | 109 x |
Net cash position 2022 | 472M 5.66M 7.72M | Net cash position 2023 | 2.27B 27.2M 37.1M | EV / Sales 2023 | 61.1 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-7.31
x | Employees | 132 |
Yield 2022 |
1.08% | Yield 2023 |
-
| Free-Float | 28.95% |
Latest transcript on Suven Life Sciences Limited
1 day | +0.99% | ||
1 week | +8.17% | ||
Current month | +12.55% | ||
1 month | +7.19% | ||
3 months | +7.45% | ||
6 months | +49.07% | ||
Current year | +39.38% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 20-01-09 |
Shrenik Soni
CMP | Compliance Officer | - | 20-01-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
Sudha Rani Jasti
FOU | Founder | 70 | 89-03-08 |
Director/Board Member | 70 | 10-04-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 112.6 | +0.99% | 68 258 |
24-04-26 | 111.4 | -1.89% | 169,884 |
24-04-25 | 113.6 | +1.02% | 558,699 |
24-04-24 | 112.4 | +5.00% | 236,641 |
24-04-23 | 107.1 | +2.93% | 480,657 |
Delayed Quote NSE India S.E., April 29, 2024 at 01:41 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SUVEN Stock
- SUVEN Stock